Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ... Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
REFERENCES Chung K. K., Dawson V. L. and Dawson T. M. (2001) The role of the ubiquitin–proteasomal 188 pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci. 24, S7–S14. Chung K. K., Thomas B., Li X., Pletnikova O., Troncoso J. C., Marsh L., Dawson V. L. and Dawson T. M. (2004) S-nitrosylation of parkin regulates ubiquitination and compromises parkin's protective function. Science 304, 1328–1331. Cicchetti F., Brownell A. L., Williams K., Chen Y. I., Livni E. and Isacson O. (2002) Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur. J. Neurosci. 15, 991– 998. Clarke C. E. and Guttman M. (2002) Dopamine agonist monotherapy in Parkinson’s disease. Lancet 360, 1767–1769. Claveria L. E., Duarte J., Sevillano M. D., Pérez-Sempere A., Cabezas C., Rodríguez F. and de Pedro-Cuesta J. (2002) Prevalence of Parkinson’s disease in Cantalejo, Spain: a door-to- door survey. Mov. Disord. 17, 242–249. Colomina M. T., Roig J. L., Sánchez D. J. and Domingo J. L. (2002) Influence of age on aluminum-induced neurobehavioral effects and morphological changes in rat brain. Neurotoxicology 23, 775–781. Constantini S. and Giordano R. (1991) Aluminium determination in complex matrixes, in Aluminum in Chemistry, Biology and Medicine, (Nicolini M., Zatta P. F. and Corain B., eds), pp. 21–29. Raven Press, New York. Conway K. A., Rochet J. C., Bieganski R. M., Lansbury Jr. P. T. (2001) Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294, 1346– 1349. Cookson M. R. (2005) The biochemistry of Parkinson's disease. Annu. Rev. Biochem. 74, 29–52.
REFERENCES Cooper J. R., Bloom F. E. and Roth R. H. (1996) Dopamine, in The Biochemical Basis of Neuropharmacology (Cooper J. R., Bloom F. E. and Roth R. H., eds), 7th edn, pp. 293–351, Oxford University Press, New York. Cordeiro J. M., Silva V. S., Oliveira C. R. and Goncalves P. P. (2003) Aluminium-induced impairment of Ca 2+ modulatory action on GABA transport in brain cortex nerve terminals. J. Inorg. Biochem. 97, 132–142. Crapper D. R., Krishnan S. S. and Dalton A. J. (1973) Brain aluminum distribution in Alzheimer's disease and experimental neurofibrillary degeneration. Science 180, 511–513. Cronan C. S. and Schofield C. L. (1979) Aluminum leaching response to acid precipitation: effects on high-elevation watersheds in the northeast. Science 204, 304–306. Cutillas B., Espejo M., Gil J., Ferrer I. and Ambrosio S. (1999) Caspase inhibition protects nigral neurons against 6-OHDA-induced retrograde degeneration. Neuroreport 10, 2605–2608. Czlonkowska A., Kohutnicka M., Kurkowska-Jastrzebska I. and Czlonkowski A. (1996) Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson’s disease mice model. Neurodegeneration 5, 137–143. Danielson S. R. and Andersen J. K. (2008) Oxidative and nitrative protein modifications in Parkinson's disease. Free Radic. Biol. Med. 44, 1787–1794. Darios F., Corti O., Lücking C. B., Hampe C., Muriel M. P., Abbas N., Gu W. J., Hirsch E. C., Rooney T., Ruberg M. and Brice A. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria-dependent cell death. Hum. Mol. Genet. 12, 517– 526. Dauer W. and Przedborski S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889–909. Davie C. A. (2008) A review of Parkinson’s disease. Br. Med. Bull. 86, 109–127. 189
- Page 162 and 163: CHAPTER 3 Fig. 1 Levels of TBARS (A
- Page 164 and 165: CHAPTER 3 Fig. 2 Enzyme activity of
- Page 166 and 167: CHAPTER 3 Fig. 3 Microphotographs s
- Page 168 and 169: CHAPTER 3 Fig. 5 Levels of TBARS (A
- Page 170 and 171: CHAPTER 3 Fig. 6 In vitro effects o
- Page 173: SUMMARY
- Page 176 and 177: SUMMARY values were attained at 48
- Page 178 and 179: SUMMARY neurodegeneration in the DA
- Page 181 and 182: CONCLUSIONS The results obtained in
- Page 183: 13) Aluminium does affect neither M
- Page 187 and 188: RESUMEN RESUMEN Desde el punto de v
- Page 189 and 190: RESUMEN zonas cerebrales excepto en
- Page 191: CONCLUSIONES
- Page 194 and 195: CONCLUSIONES Capítulo 2 4) La admi
- Page 196 and 197: CONCLUSIONES 172 En base a las conc
- Page 199 and 200: Publications as a direct result fro
- Page 201: REFERENCES
- Page 204 and 205: REFERENCES Agil A., Duran R., Barre
- Page 206 and 207: REFERENCES Baquet Z. C., Bickford P
- Page 208 and 209: REFERENCES 184 1,2,3,6-tetrahydropy
- Page 210 and 211: REFERENCES 186 compacta of the subs
- Page 214 and 215: REFERENCES Davies K. J. (2001) Degr
- Page 216 and 217: REFERENCES Dhillon A. S., Tarbutton
- Page 218 and 219: REFERENCES Ekstrand M. I., Falkenbe
- Page 220 and 221: REFERENCES Fleming S. M., Delville
- Page 222 and 223: REFERENCES Ghribi O., Dewitt D. A.,
- Page 224 and 225: REFERENCES Good P. F., Olanow C. W.
- Page 226 and 227: REFERENCES Hamilton E. I., Miniski
- Page 228 and 229: REFERENCES Hirsch E. C., Brandel J.
- Page 230 and 231: REFERENCES Inden M., Kitamura Y., T
- Page 232 and 233: REFERENCES Johnson V. J. and Sharma
- Page 234 and 235: REFERENCES Kim W. G., Mohney R. P.,
- Page 236 and 237: REFERENCES Kuhn W., Winkel R., Woit
- Page 238 and 239: REFERENCES 214 K.D. and Polymeropou
- Page 240 and 241: REFERENCES Maraganore D. M., Lesnic
- Page 242 and 243: REFERENCES McCord J. M. and Fridovi
- Page 244 and 245: REFERENCES Miu A. C. and Benga O. (
- Page 246 and 247: REFERENCES Nair V. D., McNaught K.,
- Page 248 and 249: REFERENCES Onyango I. G. (2008) Mit
- Page 250 and 251: REFERENCES Perez F. A. and Palmiter
- Page 252 and 253: REFERENCES Przedborski S. and Goldm
- Page 254 and 255: REFERENCES Rifat S. L., Eastwood M.
- Page 256 and 257: REFERENCES Rymar V. V., Sasseville
- Page 258 and 259: REFERENCES Savory J., Herman M. M.
- Page 260 and 261: REFERENCES Shimizu H., Mori T., Koy
REFERENCES<br />
Chung K. K., Dawson V. L. and Dawson T. M. (2001) The role <strong>of</strong> the ubiquit<strong>in</strong>–proteasomal<br />
188<br />
pathway <strong>in</strong> Park<strong>in</strong>son's disease and other neurodegenerative disorders. Trends Neurosci.<br />
24, S7–S14.<br />
Chung K. K., Thomas B., Li X., Pletnikova O., Troncoso J. C., Marsh L., Dawson V. L. and Dawson<br />
T. M. (2004) S-nitrosylation <strong>of</strong> park<strong>in</strong> regulates ubiquit<strong>in</strong>ation and compromises park<strong>in</strong>'s<br />
protective function. Science 304, 1328–1331.<br />
Cicchetti F., Brownell A. L., Williams K., Chen Y. I., Livni E. and Isacson O. (2002)<br />
Neuro<strong>in</strong>flammation <strong>of</strong> the nigrostriatal pathway dur<strong>in</strong>g progressive 6-OHDA dopam<strong>in</strong>e<br />
degeneration <strong>in</strong> rats monitored by immunohistochemistry and PET imag<strong>in</strong>g. Eur. J.<br />
Neurosci. 15, 991– 998.<br />
Clarke C. E. and Guttman M. (2002) Dopam<strong>in</strong>e agonist monotherapy <strong>in</strong> Park<strong>in</strong>son’s disease.<br />
Lancet 360, 1767–1769.<br />
Claveria L. E., Duarte J., Sevillano M. D., Pérez-Sempere A., Cabezas C., Rodríguez F. and de<br />
Pedro-Cuesta J. (2002) Prevalence <strong>of</strong> Park<strong>in</strong>son’s disease <strong>in</strong> Cantalejo, Spa<strong>in</strong>: a door-to-<br />
door survey. Mov. Disord. 17, 242–249.<br />
Colom<strong>in</strong>a M. T., Roig J. L., Sánchez D. J. and Dom<strong>in</strong>go J. L. (2002) Influence <strong>of</strong> age on<br />
alum<strong>in</strong>um-<strong>in</strong>duced neurobehavioral effects and morphological changes <strong>in</strong> rat bra<strong>in</strong>.<br />
Neurotoxicology 23, 775–781.<br />
Constant<strong>in</strong>i S. and Giordano R. (1991) Alum<strong>in</strong>ium determ<strong>in</strong>ation <strong>in</strong> complex matrixes, <strong>in</strong><br />
Alum<strong>in</strong>um <strong>in</strong> Chemistry, Biology and Medic<strong>in</strong>e, (Nicol<strong>in</strong>i M., Zatta P. F. and Cora<strong>in</strong> B., eds),<br />
pp. 21–29. Raven Press, New York.<br />
Conway K. A., Rochet J. C., Bieganski R. M., Lansbury Jr. P. T. (2001) K<strong>in</strong>etic stabilization <strong>of</strong> the<br />
alpha-synucle<strong>in</strong> prot<strong>of</strong>ibril by a dopam<strong>in</strong>e-alpha-synucle<strong>in</strong> adduct. Science 294, 1346–<br />
1349.<br />
Cookson M. R. (2005) The biochemistry <strong>of</strong> Park<strong>in</strong>son's disease. Annu. Rev. Biochem. 74, 29–52.
Change language